MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
LXRX — Lexicon Pharmaceuticals, Inc.
NasdaqLexicon Pharmaceuticals, Inc.
$1.75
+0.01(+0.57%)
- O
- 1.75
- H
- 1.78
- L
- 1.72
- V
- 1.55M
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About LXRX
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateApr 7, 2000
Employees81
Stock ExchangeNasdaq
Ticker SymbolLXRX
Websitehttps://www.lexpharma.com
Key Financial Statistics
| Market Cap | $809.82M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.10 - $2.68 |
| 52-Week Avg Volume | 2.77M |
| VWAP | $1.75 |
| Transactions | 6,599 |
| Total Recorded Bars | 6,662 days |